Therefore, measurement of sLHCGR/LH-sLHCGR following embryo transfer together with targeted hCG therapy could improve pregnancy outcome by extending the window of implantation and simultaneously reducing the frequency of miscarriage. This evidence concerns the gene PLOD1 and spontaneous abortion.